Cytokine production in primary histoculture by human normal kidney, renal cell carcinoma and benign renal angiomyolipoma tissues

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4195-4200

  Chang, Sung Goo ^a,b   Shin, Churchil ^a   Rho, Sei Kyung ^a   Kim, Duk Kyo ^a   Kim, Jung Hae ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Cytokine; Histoculture; Human kidney; Renal angiomyolipoma; Renal cell carcinoma

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOMYOLIPOMA; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; NORMAL HUMAN; PRIORITY JOURNAL; TISSUE CULTURE;

ANGIOMYOLIPOMA; CARCINOMA, RENAL CELL; CELL DIVISION; CYTOKINES; DNA REPLICATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-11; INTERLEUKIN-6; KIDNEY CORTEX; KIDNEY NEOPLASMS; MITOTIC INDEX; ORGAN CULTURE TECHNIQUES; REFERENCE VALUES; THYMIDINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032423526     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yoshida M, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GR, Huben R, and Sandberg AA: Cytogenetic studies of tumor tissue from patient with nonfamilial renal cell carcinoma. Cancer Res 46: 2139-2147, 1986.
2. Larsson P: Cell proliferation in renal cell carcinoma. Scan J Urol Nephrol 165: 1-48, 1994.
3. Hayakawa M, Hatano T, Ogawa T, Gakiya M, Ogura H, and Osawa A: Treatment of advanced renal cell carcinoma using regional arterial administration of lymphokin-activated killer cells in combination with low doses of rIL-2. Urol Int 53: 117-124, 1994.
4. Takenawa J, Kanako Y, Fukyomoto M, Fukatsu A, Hirano T, Fukuyama H, Nakayama F, Fujita J, and Yoshida O: Enhanced expression of IL-6 in primary human renal cell carcinoma. J Natl Cancer Inst 3: 1668-1672, 1991.
5. Philips AO, Steadman R, Topley N, and Williams JD: Elevated D-glucose concentrations modulate TGF-beta-1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am J Pathol 147: 362-374, 1995.
6. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K et al: Interleukin-6(IL-6) function as in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett 250: 607-610, 1989.
7. Barnard JA, Lyons RM, and Moses HM: The cell biology of transformation growth factor beta. Biochem Biophys Acta 1032: 79-87, 1990.
8. Knoefel B, Nuske K, Steiner T, Junker K, Kosmehl H, Rebstock K, et al: Renal cell carcinomas produce IL-6, IL-10, IL-11 and TGF-beta-1 in primary cultures and modulate T-lymphocyte blast formation. J Interferon Cytokine Res 17: 95-102, 1997.
9. Tsukamoto T, Kumamoto Y, Miyao N, Masumori N, Takahashi A, and Yanase M: Interleukin-6 in renal cell carcinoma. J Urol 148: 1778-1782, 1992.
10. Chang S-G, Lee SJ, Lee S-J, Kim JI, Jung J-C, Kim JH, and Hoffman RM: Interleukin-6 production in primary histoculture by normal human kidney and renal tumor tissues. Anticancer Res 17: 113-116, 1997.
11. Blay JY, Schemann S, and Favrot MC: Local production of interleukin-6 by renal adenocarcinoma in vitro. J Natl Cancer Inst 86: 238, 1994.
12. Filguerira L, Zuber M, Merlo A, Caetano V, Schultz E, Harder F, Spagnoli GC, and Heberer M: Cytokine gene transcription in renal cell carcinoma. Br J Surg 80: 1322-1325, 1993.
13. Gogusev J, Augusti M, Chretien Y, and Droz D: Interleukin-6 and tumor necrosis factor-alpha production in human renal cell carcinoma. Kidney Int 44: 585-592, 1993.
14. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, and Dinarello CA: Correlations and interactions in the production of interleukin-6, IL-1, and tumor necrosis factor in human blood mononuclear cells: IL-6 suppresses IL-1 and tumor necrosis factor. Blood 75: 40-47, 1990.
15. Dosquet C, Schaetz A, Faucher C, Lepage E, Wautier JL, Richard F, and Cabane J: Tumor necrosis factor-alpha, interleukin-1-beta and interleukin-6 in patient with renal cell carcinoma. Eur J Cancer, 30A: 162-167, 1994.
16. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A et al: Serum level of interleukin-6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52: 3317-3322, 1992.
17. Fukatsu A, Matsuo S, Tami H, Sakamoto N, Matsuda T, and Hirano T: Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest 65: 61-66, 1991.
18. Ruef C, Bodde K, Lacy J, Northemann W, Baumann M, Sterzl RB, Coleman DL: Interleukin-6 is an autocrine growth factor for mesangial cells. Kidney Int 38: 249-257, 1990.
19. Freeman AE, and Hoffman RM: In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83: 2694-2698, 1986.
20. Hoffman RM: Three-dimensional histoculture: Origins and applications in cancer research. Cancer Cells 3: 86-92, 1991.